cefmetazole has been researched along with E coli Infections in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (29.41) | 18.7374 |
1990's | 5 (29.41) | 18.2507 |
2000's | 1 (5.88) | 29.6817 |
2010's | 2 (11.76) | 24.3611 |
2020's | 4 (23.53) | 2.80 |
Authors | Studies |
---|---|
Enoki, Y; Hayashi, M; Igarashi, Y; Kojima, N; Liu, X; Matsumoto, K; Mizukami, Y; Morita, T; Nakamura, T; Taguchi, K; Takemura, W; Tashiro, S; Yokoyama, Y | 1 |
Doi, Y; Hamada, Y; Hara, H; Hase, R; Hashimoto, T; Hayakawa, K; Kato, H; Matono, T; Matsumura, Y; Mawatari, M; Ohmagari, N; Saito, S; Sakurai, A; Shinohara, K; Tanizaki, R; Tsuzuki, S; Uemura, K | 1 |
Abe, Y; Fukuma, A; Hirade, T; Horie, A; Ito, T; Katou, F; Koike, D; Nariai, A; Saito, Y; Wakuri, M | 1 |
Mitsui, S; Mizuki, S; Tauchi, S; Tobe, S | 1 |
Akazawa, T; Doi, Y; Hamada, Y; Hayakawa, K; Matsumura, Y; Nagashima, M | 1 |
Hiraki, K; Murakami, N; Sugawara, T; Uetake, N | 1 |
Chang, LY; Hsueh, PR; Huang, LM; Lee, CY; Lee, PI; Lu, CY; Shao, PL; Wang, CY; Wu, TZ; Yang, CY | 1 |
Nishino, T; Saito, M; Saito, T; Shibata, K; Tanino, T; Yano, K | 1 |
Aoki, M; Isono, M; Kawashima, K; Kobayashi, T; Sawa, K; Ueno, K; Watanabe, K; Yamada, N | 1 |
Fujii, R; Hashira, S; Matsueda, Y | 1 |
Galandiuk, S; Lamos, J; Montgomery, W; Polk, HC; Young, S | 1 |
Brook, I | 2 |
Hopkins, JA; Lami, JL; Wilson, SE | 1 |
Ajiki, Y; Koga, T; Ohya, S; Takenouchi, T; Ueno, K; Watanabe, K; Yasuda, H | 1 |
Castilla, C; Fernández-Roblas, R; Ponte, C; Santamaría, M; Soriano, F | 1 |
Hirai, Y; Imamura, K; Kumasaka, Y; Nakahata, H; Senda, H; Suzuki, I; Takebe, K | 1 |
1 trial(s) available for cefmetazole and E coli Infections
Article | Year |
---|---|
Adjunctive antimicrobials in surgery of soft tissue infections: evaluation of cephalosporins and carbapenems.
Topics: Adult; Aged; Bacterial Infections; Carbapenems; Cefmetazole; Cefoperazone; Cefotetan; Cefoxitin; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Remission Induction; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections; Thienamycins | 1991 |
16 other study(ies) available for cefmetazole and E coli Infections
Article | Year |
---|---|
Cefmetazole as an Alternative to Carbapenems Against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Infections Based on In Vitro and In Vivo Pharmacokinetics/Pharmacodynamics Experiments.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefmetazole; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Mice; Microbial Sensitivity Tests; Neutropenia | 2021 |
Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum β-lactamase-producing
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefmetazole; Escherichia coli; Escherichia coli Infections; Humans; Meropenem; Urinary Tract Infections | 2023 |
Increased community-acquired upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in children and the efficacy of flomoxef and cefmetazole.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamases; Cefmetazole; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia; Escherichia coli Infections; Escherichia coli Proteins; Female; Genotype; Humans; Infant; Infant, Newborn; Male; O Antigens; Retrospective Studies; Urinary Tract Infections; Virulence | 2019 |
Extended-spectrum β-lactamase-producing
Topics: Abscess; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Cefmetazole; Debridement; Escherichia coli Infections; Humans; Male; Negative-Pressure Wound Therapy; Osteomyelitis; Ribs; Sepsis; Thoracic Wall; Tomography, X-Ray Computed; Urinary Tract Infections | 2021 |
Retrospective evaluation of appropriate dosing of cefmetazole for invasive urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefmetazole; Escherichia coli; Escherichia coli Infections; Humans; Retrospective Studies; Urinary Tract Infections | 2021 |
[Evaluation of Antibiotics for the Treatment of Bacteremia Due to Extended-spectrum β-Lactamase-producing Escherichia coli].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cefmetazole; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk; Treatment Outcome; Young Adult | 2015 |
Infections of cefotaxime-resistant and cefmetazole-susceptible Escherichia coli and Klebsiella pneumoniae in children.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheterization; Cefmetazole; Cefotaxime; Child; Child, Preschool; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Heart Defects, Congenital; Humans; Immunologic Deficiency Syndromes; Infant; Inpatients; Klebsiella Infections; Klebsiella pneumoniae; Male; Neoplasms; Premature Birth; Taiwan | 2005 |
Therapeutic effect of cefotetan in an experimental local infection with facultative and obligate anaerobes in granuloma pouches in rats.
Topics: Animals; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefazolin; Cefmetazole; Cefotetan; Cephamycins; Escherichia coli Infections; Fusobacterium Infections; Male; Microscopy, Electron, Scanning; Rats; Rats, Inbred Strains; Serratia marcescens | 1984 |
[In vitro and in vivo antimicrobial activities of cefmetazole against Bacteroides fragilis].
Topics: Animals; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Cefmetazole; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Stability; Escherichia coli Infections; Male; Mice; Mice, Inbred ICR | 1982 |
[Laboratory and clinical evaluation of cefmetazole in the newborn infants (author's transl)].
Topics: Anti-Bacterial Agents; Bacterial Infections; Blood Transfusion; Cefmetazole; Cephamycins; Drug Evaluation; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Injections, Intravenous; Male | 1981 |
Antibiotic penetration of experimental intra-abdominal abscesses.
Topics: Abdominal Abscess; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cefmetazole; Cefoxitin; Ceftriaxone; Clindamycin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Escherichia coli Infections; Hydrogen-Ion Concentration; Male; Mice; Microbial Sensitivity Tests; Spectinomycin; Sulbactam | 1995 |
Prophylaxis of and therapy for polymicrobial infection in mice with cefoxitin, cefotetan, and cefmetazole.
Topics: Abdomen; Abscess; Animals; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefmetazole; Cefotetan; Cefoxitin; Drug Evaluation, Preclinical; Escherichia coli Infections; Male; Mice | 1993 |
Use of cephalosporins for prophylaxis and therapy of polymicrobial infection in mice.
Topics: Abdomen; Abscess; Animals; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefmetazole; Cefotetan; Cefoxitin; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Male; Mice; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus | 1993 |
beta-Lactamase produced by a highly beta-lactam-resistant strain of Bacteroides fragilis: an obstacle to the chemotherapy of experimental mixed infections.
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Cefmetazole; Cephalosporins; Drug Resistance, Microbial; Escherichia coli Infections; Exudates and Transudates; Male; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Substrate Specificity | 1991 |
In vivo significance of the inoculum effect of antibiotics on Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Cefmetazole; Cefotaxime; Cefoxitin; Cephamycins; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains | 1988 |
[In vivo antibacterial activity of cefbuperazone. Synergy of cefbuperazone for bactericidal effect with human polymorphonuclear leukocytes].
Topics: Animals; Blood Bactericidal Activity; Cefmetazole; Cefoperazone; Cefotetan; Cephamycins; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred ICR; Moxalactam; Neutrophils | 1986 |